Delivery Order SPE2DB20D3103-SPE2DB25FL7L4

Award Date 11/21/24
Potential Completion Date 11/22/24
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,080.22, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 0.9% sodium chloride solution in 100ml containers. This award is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a wide range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,199.19 Firm Fixed Price delivery order is for the provision of 50mL sodium chloride 0.9% solution, with a period of performance through October 2024. This award is a task order under Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This federal contract award, valued at $1,998.65, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The contract is a delivery order for the supply of 50 mL sodium chloride 0.9% solution, a critical medical supply. Amerisourcebergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA Troop Support Medical through...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a $1,366.91 firm-fixed-price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical for the supply of 0.9% sodium chloride solution in 100 milliliter containers. The award has no set-aside designation and is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between Amerisourcebergen and the DLA through December 2025 for the provision of a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,481.24 firm fixed-price delivery order is for the supply of 0.9% sodium chloride solution in 100 mL containers. The contract has an ultimate completion date of November 27, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, valued at $13,346.36, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4563333871 - Sodium Chloride 0.9% Solution 100ML, with a firm fixed price and an ultimate completion date of January 17, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,522.91 firm-fixed-price delivery order is for the supply of a 0.9% sodium chloride solution in 100 ml vials, with a performance period ending on November 28, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 0.9% sodium chloride solution in 250 mL volumes. The $1,840.28 firm fixed-price contract has an ultimate completion date of August 2, 2022. Amerisourcebergen is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
This federal contract award, valued at $4,322.75, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a delivery order for the provision of sodium chloride 0.9% solution in 100ml containers. This award does not have a set-aside designation and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this IDC,...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Sodium Chloride 0.9% Solution 100ML, a common medical product, with a ceiling value of $2,353.73 and a completion date of December 26, 2023. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FL7L4
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, valued at $2,067.70, is a Delivery Order issued by the Defense Logistics Agency (DLA) under the company's existing Indefinite Delivery Contract (IDC) valued at $999,999,999. The contract is for the delivery of sodium chloride 0.9% solution in 100mL containers, a critical medical supply used in various healthcare settings. As an open competition award with no set-aside designation, Amerisourcebergen, a major pharmaceutical distributor and healthcare solutions provider, will be responsible for supplying this product to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions across the United States. The contract has a period of performance through November 2024, demonstrating Amerisourcebergen's ongoing role as a key vendor for the DLA and the broader federal government's pharmaceutical and medical supply procurement needs.

Generated 2/27/25, 11:52 AM